EC Number   |
Title |
Organism |
|---|
   2.4.1.150 | Engagement of I-branching beta-1,6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-beta signaling |
Homo sapiens |
| 2.4.1.150 | GCNT2 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma cells |
Homo sapiens |
| 2.4.1.150 | MiR-BART1-5p targets core 2beta-1,6-acetylglucosaminyltransferase GCNT3 to inhibit cell proliferation and migration in EBV-associated gastric cancer |
Homo sapiens |
| 2.4.1.150 | Pleiotropic effect of a novel mutation in GCNT2 causing congenital cataract and a rare adult i blood group phenotype |
Homo sapiens |
| 2.4.1.150 | Small-molecule inhibition of GCNT3 disrupts mucin biosynthesis and malignant cellular behaviors in pancreatic cancer |
Homo sapiens |
| 2.4.1.150 | Small-molecule inhibition of GCNT3 disrupts mucin biosynthesis and malignant cellular behaviors in pancreatic cancer |
Mus musculus |
| 2.4.1.150 | Small-molecule inhibition of GCNT3 disrupts mucin biosynthesis and malignant cellular behaviors in pancreatic cancer |
Mus musculus C5BL/6 |
| 2.4.1.150 | The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance |
Homo sapiens |
| 2.4.1.150 | A novel variant form of murine beta-1,6-N-acetylglucosaminyltransferase forming branches in poly-N-acetyllactosamines |
Mus musculus |
| 2.4.1.150 | Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes |
Danio rerio |
